Domain Therapeutics
PrivateLast Round
Series B
Feb 10, 2026
Total Funding Raised
$72.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kainova Therapeutics is a biopharmaceutical company that develops breakthrough therapies targeting G protein-coupled receptors (GPCRs) for the treatment of immuno-oncology and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Domain Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Domain Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 10, 2026 | ||||
| Grant | Jan 25, 2024 | ||||
| Series A | May 10, 2022 | ||||
| Grant | Jan 27, 2022 | ||||
| Debt | Jan 13, 2020 | ||||
VC Round | May 28, 2019 |
Key People
Founding team and executive leadership
Domain Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investissement Québec | Series B |
| Idinvest Partners | VC Round |
| CTI Life Sciences Fund | Series B, Series A |
| Alsace Inter Regio Fonds d’Investissement | VC Round |
| Andera Partners | VC Round |
| Agence Nationale de la Recherche | Grant |
| 3B FUTURE Health Fund | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2026
$24M round led by Investissement Québec
- Nov 13, 2025
Jean-Marie Cuillerot, M.D. appointed as new CMO.
Domain Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Domain Therapeutics's valuation, stock price, and market status.